Invention Grant
- Patent Title: Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
-
Application No.: US15988736Application Date: 2018-05-24
-
Publication No.: US10526313B2Publication Date: 2020-01-07
- Inventor: Kenneth M. Rosen , Matthew D. Abbinanti , Joerg Ruschel , Lisa Mckerracher , Lisa Bond Moritz
- Applicant: BioAxone BioSciences, Inc.
- Applicant Address: US MA Boston
- Assignee: BioAxone BioSciences, Inc.
- Current Assignee: BioAxone BioSciences, Inc.
- Current Assignee Address: US MA Boston
- Agency: Clark & Elbing LLP
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07C55/14 ; C07B59/00 ; A61K31/4725 ; A61K45/06 ; A61K31/4545 ; A61K31/551
Abstract:
BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.
Public/Granted literature
- US20180297982A1 RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF Public/Granted day:2018-10-18
Information query
